2855.2000 -25.15 (-0.87%)
NSE Apr 01, 2025 12:20 PM
Volume: 34,640
 

2855.20
-0.87%
Karvy
Revenues for the quarter at Rs 7880 mn were below our estimates of Rs 8195 mn. The operating margins at 21% in Q1FY20 were below our estimates of 23.2% on account of lower revenue traction and lower gross margin.
Number of FII/FPI investors increased from 337 to 347 in Dec 2024 qtr.
More from GlaxoSmithKline Pharmaceuticals Ltd.
Recommended